
Cinpar 37.5mg Tablet CR
Marketer
Cinerea Biotech Pvt Ltd
Salt Composition
Paroxetine (37.5mg)
Overview Cinpar 37.5mg Tablet CR
Deplin 37.5mg extended-release tablets are a selective serotonin reuptake inhibitor (SSRI) antidepressant medication. Frequently prescribed for depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks, Deplin 37.5mg helps many patients improve their mood and reduce anxiety and tension, aiding recovery from depression. Consumption is independent of meals; dosage and frequency are determined by your physician for optimal symptom management, often starting with a lower dose and gradually increasing. Never alter your dosage or discontinue use without consulting your doctor; doing so could worsen your condition or trigger unpleasant withdrawal effects (e.g., anxiety, agitation, rapid heartbeat, lightheadedness, sleep disruption). For maximum effectiveness, take consistently at the same time daily, preferably morning if sleep disturbance occurs. Significant improvement may take several weeks; report lack of progress after four weeks. Common side effects include nausea, tiredness, dry mouth, decreased appetite, increased perspiration, dizziness, nervousness, shaking, insomnia, and constipation. Reduced libido, delayed ejaculation, and impotence may also occur. Immediately report sudden mood changes or suicidal thoughts. Inform your physician of epilepsy, diabetes, liver or kidney impairment, heart conditions, or glaucoma before starting treatment, as these factors may influence efficacy. Pregnant or breastfeeding individuals should also seek medical advice. Interactions may occur with other medications, particularly other antidepressants and MAO inhibitors; fully disclose all current medications to your doctor for safety.
Uses of Cinpar 37.5mg Tablet CR
Managing depressive disorders | Addressing panic attacks and panic disorder | Coping with anxiety disorders
Major Benefits of Cinpar 37.5mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cinpar 37.5mg Controlled-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Cinpar 37.5mg Tablet CR:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Cinpar 37.5mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cinpar 37.5mg Controlled-Release Tablets can be consumed with or without food, however, consistent timing is recommended.
How Cinpar 37.5mg Tablet CR works:
Cinpar 37.5mg Controlled-Release tablets are an antidepressant medication classified as a selective serotonin reuptake inhibitor (SSRI). Their mechanism of action involves elevating serotonin concentrations in the brain, a neurotransmitter crucial for mood regulation. Consequently, this boosts mood and alleviates both the emotional and physical manifestations of depression, as well as the symptoms of panic attacks, anxiety, and obsessive-compulsive disorder.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cinpar 37.5mg Tablet CR and alcohol is not advisable due to safety concerns.
PregnancyUNSAFE
Use of Cinpar 37.5mg Tablet CR is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animals and humans indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Cinpar 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with possible infant harm.
DrivingUNSAFE
Taking a Cinpar 37.5mg Controlled-Release tablet could reduce awareness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Cinpar 37.5mg extended-release tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Cinpar 37.5mg controlled-release tablets cautiously. Dosage modification for Cinpar 37.5mg controlled-release tablets may be necessary; physician consultation is advised.
What if you forget to take Cinpar 37.5mg Tablet CR :
For Cinpar 37.5mg CR Tablets, take a missed dose as quickly as you remember. If it's nearly time for your next scheduled dose, however, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Cinpar 37.5mg Tablet CR
| Label | Value |
|---|---|
| Chemical Type | Phenylpiperidine Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Selective serotonin reuptake inhibitors (SSRIs) |
